Antimutagenic Hypoxen activity in vivo
Animal research · 2002
- What was studied
- C57BL/6 mouse bone-marrow chromosome-aberration assay
- Main finding
- Simultaneous injected Hypoxen reduced dioxidine-associated genotoxicity by a reported 35% over 24 hours. Five-day oral pretreatment did not reduce damage.
Study data at a glance
- Participants or experimental model
- C57BL/6 mouse bone-marrow chromosome-aberration assay
- Reported results
- Simultaneous injected Hypoxen reduced dioxidine-associated genotoxicity by a reported 35% over 24 hours. Five-day oral pretreatment did not reduce damage.
Study limitations and source details
Study limitations
- Route- and timing-dependent results; the oral negative finding must be retained.
- A mouse mutagen assay does not establish protection against industrial gases, benzene or cancer.
Source details
Journal article
Indexed or publisher abstract reviewed; full methods and risk of bias not appraised.
Abstract reviewed
Sources checked
Citation
O. A. Karpova, L. V. Mikhina, A. A. Denisov, M. K. Kuzmich. Antimutagenic Hypoxen activity in vivo Experimental and Clinical Pharmacology. 65(3):54–56